Exploration of genetic health professional - laboratory specialist interactions in diagnostic genomic sequencing.


Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 09 07 2019
revised: 14 08 2019
accepted: 24 08 2019
pubmed: 1 9 2019
medline: 20 11 2020
entrez: 1 9 2019
Statut: ppublish

Résumé

Like any new technology, rapid integration of genomic sequencing (GS) into the clinical setting can pose challenges for genetic health professionals (GHPs) using it to diagnose patients. We conducted semi-structured interviews with 31 clinical geneticists and genetic counsellors across Europe, Australia and Canada to gain a better understanding of the issues they were experiencing when requesting GS and receiving reports from laboratories. There was a spectrum of interactions between genetic health professionals and laboratories. This ranged from those that almost exclusively request sequencing from the laboratory that is affiliated with their genetic service, to those who do not have access to exome sequencing 'in-house' and instead send patient samples to a selection of different external laboratories. In general, a closer interaction between the clinicians and the laboratory scientists increased the involvement of the clinicians in the analysis/interpretation process. This appeared to lead to fewer, but more clinically relevant variants being reported, and greater GHP satisfaction in what is reported. Our findings suggest that GHPs consider integration of clinical expertise into the analysis/interpretation process is critical to ensure that the variants reported are of high clinical significance to patients. They also highlight the importance of providing GHPs with training in report interpretation.

Identifiants

pubmed: 31472303
pii: S1769-7212(19)30465-3
doi: 10.1016/j.ejmg.2019.103749
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103749

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Danya F Vears (DF)

Melbourne Law School, University of Melbourne, Carlton, Australia; Murdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Australia; Center for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Belgium; Leuven Institute for Human Genetics and Society, Leuven, Belgium. Electronic address: dvears@unimelb.edu.au.

Karine Sénécal (K)

Centre of Genomics and Policy, McGill University, Montreal, Canada.

Pascal Borry (P)

Center for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Belgium; Leuven Institute for Human Genetics and Society, Leuven, Belgium.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH